Resmed (RMD) Accumulated Expenses (2010 - 2026)

Resmed's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $446.1 million for Q1 2026.

• Quarterly Accumulated Expenses rose 15.49% year-over-year to $446.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $446.1 million (up 15.49% YoY) and the FY2025 annual result came in at $402.3 million, up 6.51% from the prior year.
• Accumulated Expenses was $446.1 million for Q1 2026 at Resmed, up from $391.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $446.1 million in Q1 2026 and bottomed at $312.2 million in Q4 2022.
• A 5-year average of $363.2 million and a median of $356.1 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses increased 18.22% — and 2024, when it advanced 2.51%.
• Resmed's Accumulated Expenses stood at $312.2 million in 2022, then advanced by 6.4% to $332.1 million in 2023, then increased by 6.14% to $352.5 million in 2024, then advanced by 11.05% to $391.5 million in 2025, then grew by 13.96% to $446.1 million in 2026.
• Business Quant data shows RMD's Accumulated Expenses at $446.1 million in Q1 2026, $391.5 million in Q4 2025, and $395.8 million in Q3 2025.